The malignant phenotype-associated microRNA in gastroenteric, hepatobiliary and pancreatic carcinomas

Expert Opinion on Biological Therapy

Volumn 10, Issue 12, 2010, Pages 1693-1701

  Hong, Liu ^a   Han, Yu ^a   Li, Shujun ^a   Yang, Jianjun ^a   Zheng, Jianyong ^a   Zhang, Hongwei ^a   Zhao, Qingchuan ^a   Wu, Kaichun ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

antagomirs; colorectal cancer; esophageal cancer; gastric cancer; hepato biliary cancer; microRNA; pancreatic cancer

Indexed keywords

MICRORNA;

BILE DUCT CARCINOMA; CANCER GENE THERAPY; CANCER THERAPY; COLORECTAL CANCER; ESOPHAGUS CANCER; GENE EXPRESSION; HEPATOBILIARY SYSTEM CANCER; HUMAN; PANCREAS CARCINOMA; REVIEW; STOMACH CARCINOMA;

BILIARY TRACT NEOPLASMS; CARCINOMA; DIGESTIVE SYSTEM NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENOTYPE; HUMANS; INTESTINAL NEOPLASMS; LIVER NEOPLASMS; MICRORNAS; PANCREATIC NEOPLASMS; PHENOTYPE; STOMACH NEOPLASMS;

EID: 78249269171     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2010.532482     Document Type: Review

References (63)

1. Shapira I, Sultan K, Mehrotra B, Budman DR. Emerging role of small ribonucleic acids in gastrointestinal tumors. Crit Rev Oncol Hematol 2010: published online 6 Feb. 2010, doi:10.1016/j.critrevonc.2010.01.013 •• An overview of the small ribonucleic acids in gastrointestinal tumors.
2. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010;11(9):597-610
3. Fabbri M, Calin GA. Epigenetics and miRNAs in human cancer. Adv Genet 2010;70:87-99
4. Skotheim RI, Nees M. Alternative splicing in cancer: noise, functional, or systematic? Int J Biochem Cell Biol 2007;39:1432-49
5. Feber A, Xi L, Luketich JD, et al. MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg 2008;135:255-60
6. Cho WC. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol 2009: published online 22 Dec. 2009, doi: 10.1016/j.biocel.2009.12.014
7. Hong L, Han Y, Zhang H, et al. The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma Ann Surg 2010;251(6):1056-63
8. Guo Y, Chen Z, Zhang L, et al. Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 2008;68:26-33
9. Hong L, Han Y, Zhang H, et al. The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma. Ann Surg 2010;251:1056-63 • Description of the expression pattern of miRNAs in esophageal squamous cell cancer.
10. Cho WC. MicroRNAs in cancer-from research to therapy. Biochim Biophys Acta 2010;1805:209-17 •• Demonstration that miRNAs are suited to the task of cancer therapy.
11. Smith CM, Watson DI, Michael MZ, Hussey DJ. MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma. World J Gastroenterol 2010;16:531-7
12. Hong L, Li S, Liu L, et al. The value of MG7-Ag and COX-2 for predicting malignancy in gastric precancerous lesions. Cell Biol Int 2010;34(9):873-6
13. Ueda T, Volinia S, Okumura H, et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 2010;11:136-46. • An important review of gastric cancer related microRNAs.
14. Ando T, Yoshida T, Enomoto S, et al. DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect. Int J Cancer 2009;124:2367-74
15. Lai KW, Koh KX, Loh M, et al. MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer. Eur J Cancer 2010;46:1456-63
16. Su H, Yang JR, Xu T, et al. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res 2009;69(3):1135-42
17. Zhang X, Zhu W, Zhang J, et al. MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity. Biochem Biophys Res Commun 2010;395:275-80
18. Liu T, Tang H, Lang Y, et al. MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett 2009;273(2):233-42
19. Guo X, Guo L, Ji J, et al. miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer. Biochem Biophys Res Commun 2010;398(1):1-6
20. Chu D, Adler DG. Malignant biliary tract obstruction: evaluation and therapy. J Natl Compr Canc Netw 2010;8(9):1033-44
21. Chen L, Yan HX, Yang W, et al. The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma. J Hepatol 2009;50:358-69
22. Meng F, Henson R, Lang M, et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 2006;130:2113-29
23. Chen Y, Xie D, Yin Li W, et al. RNAi targeting EZH2 inhibits tumor growth and liver metastasis of pancreatic cancer in vivo. Cancer Lett 2010;297(1):109-16
24. Rachagani S, Kumar S, Batra SK. MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications. Cancer Lett 2010;292:8-16 • A specific review of pancreatic cancer related microRNAs.
25. Dillhoff M, Wojcik SE, Bloomston M. MicroRNAs in solid tumors. J Surg Res 2009;154:349-54
26. Xia L, Zhang D, Du R, et al. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 2008;123:372-9
27. Bloomston M, Frankel WL, Petrocca F, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007;297:1901-8
28. Giovannetti E, Funel N, Peters GJ, et al. MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. Cancer Res 2010;70:4528-38
29. Torrisani J, Bournet B, du Rieu MC, et al. let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. Hum Gene Ther 2009;20:831-44
30. Weiss FU, Marques IJ, Woltering JM, et al. Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer. Gastroenterology 2009;137:2136-45
31. Liu C, Yu J, Yu S, et al. MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma. J Hepatol 2010;53:98-107
32. Gramantieri L, Fornari F, Callegari E, et al. MicroRNA involvement in hepatocellular carcinoma. J Cell Mol Med 2008;12:2189-204 • An overview of miRNAs in hepatocellular carcinoma.
33. Gramantieri L, Ferracin M, Fornari F, et al. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 2007;67:6092-9
34. Shimizu S, Takehara T, Hikita H, et al. The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. J Hepatol 2010;52:698-704
35. Hoshida Y, Toffanin S, Lachenmayer A, et al. Molecular classification and novel targets in hepatocellular carcinoma: recent advancements. Semin Liver Dis 2010;30:35-51
36. Liu WH, Yeh SH, Lu CC, et al. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells. Gastroenterology 2009;136:683-93
37. Ji J, Zhao L, Budhu A, et al. Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma. J Hepatol 2010;52:690-7
38. Lieberman D. Progress and challenges in colorectal cancer screening and surveillance. Gastroenterology 2010;138:2115-26
39. Agostini M, Pucciarelli S, Calore F, et al. miRNAs in colon and rectal cancer: a consensus for their true clinical value. Clin Chim Acta 2010;411:1181-6
40. Michael MZ, O'Connor SM, van Holst Pellekaan NG, et al. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003;1:882-91 •• The first report about colorectal neoplasia related microRNAs.
41. Bandres E, Cubedo E, Agirre X, et al. Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 2006;5:29
42. Rossi S, Kopetz S, Davuluri R, et al. MicroRNAs, ultraconserved genes and colorectal cancers. Int J Biochem Cell Biol 2009: published online 2 Jun. 2009, doi: 10.1016/j.biocel.2009.05.018
43. Akao Y, Nakagawa Y, Naoe T. let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 2006;29:903-6
44. Svoboda M, Izakovicova Holla L, Sefr R, et al. Micro-RNAs miR125b and miR137 are frequently upregulated in response to capecitabine chemoradiotherapy of rectal cancer. Int J Oncol 2008;33:541-7
45. Yantiss RK, Goodarzi M, Zhou XK, et al. Clinical, pathologic, and molecular features of early-onset colorectal carcinoma. Am J Surg Pathol 2009;33:572-82
46. Chang KH, Mestdagh P, Vandesompele J, et al. MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer. BMC Cancer 2010;10:173
47. Allgayer H. Pdcd4, a colon cancer prognostic that is regulated by a microRNA. Crit Rev Oncol Hematol 2010;73:185-91
48. Chen Y, Song Y, Wang Z, et al. Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance. J Gastrointest Surg 2010;14:1170-9
49. Akao Y, Nakagawa Y, Hirata I, et al. Role of anti-oncomirs miR-143 and - 145 in human colorectal tumors. Cancer Gene Ther 2010;17:398-408
50. Slaby O, Svoboda M, Fabian P, et al. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 2007;72:397-402
51. Selcuklu SD, Donoghue MT, Spillane C. miR-21 as a key regulator of oncogenic processes. Biochem Soc Trans 2009;37:918-25
52. Krichevsky AM, Gabriely G. miR-21: a small multi-faceted RNA. J Cell Mol Med 2009;13:39-53 • Demonstration that miR-21 may play important roles in regulating oncogenic processes.
53. Wang V, Wu W. MicroRNA-based therapeutics for cancer. BioDrugs 2009;23(1):15-23
54. Hong L, Fan D. Cancer mucosa antigens: novel immunotherapeutic targets. Expert Opin Ther Targets 2008;12:749-56
55. Scaglione BJ, Salerno E, Balan M, et al. Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model. Br J Haematol 2007;139:645-57
56. Schroeder A, Levins CG, Cortez C, et al. J Intern Med 2010;267:9-21
57. Eguchi A, Dowdy SF. siRNA delivery using peptide transduction domains. Trends Pharmacol Sci 2009;30:341-5
58. Girard M, Jacquemin E, Munnich A, et al. miR-122, a paradigm for the role of microRNAs in the liver. J Hepatol 2008;48:648-56
59. Garzon R, Calin GA, Croce CM. MicroRNAs in cancer. Annu Rev Med 2009;60:167-79
60. van Mil A, Doevendans PA, Sluijter JP. The potential of modulating small RNA activity in vivo. Mini Rev Med Chem 2009;9:235-48
61. Fei J, Lan F, Guo M, et al. Inhibitory effects of anti-miRNA oligonucleotides (AMOs) on A549 cell growth. J Drug Target 2008;16(9):688-93
62. Jankovic R, Radulovic S, Brankovic-Magic M. siRNA and miRNA for the treatment of cancer. J BUON 2009;14:43-9 • An overview of siRNA and miRNA in cancer.
63. JSeto AG. The road toward microRNA therapeutics. Int J Biochem Cell Biol 2010: published online 19 May 2010, doi: 10.1016/j.biocel.2010.03.003